Improving nutrition for ICU survivors
Does the Use of Supplemental Parenteral/Enteral Nutrition and/or Oral Nutrition Supplements Guided by Indirect Calorimetry Combined With Standard of Care Increases Energy Feeding Adequacy in Patients Who Survived Critical Illness?
This study is testing a new way to improve nutrition for people recovering from serious illness in the ICU to help them get the calories they need as they move to regular hospital care.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Universitair Ziekenhuis Brussel Academic / other |
| Locations | 1 site (Brussels) |
| Trial ID | NCT06023251 on ClinicalTrials.gov |
What this trial studies
This study aims to enhance caloric intake in patients who have survived critical illness and are transitioning to ward care. It employs a proactive nutritional strategy that includes supplemental parenteral and/or enteral nutrition, as well as oral nutritional supplements, all guided by indirect calorimetry. The goal is to address the often-overlooked issue of malnutrition in ICU survivors through a newly developed clinical pathway and a single point of contact for nutritional care.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who have spent at least 7 days in the ICU and are transitioning to ward care.
Not a fit: Patients under 18 years, those with less than 7 days in the ICU, or those receiving palliative care may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve the nutritional status and recovery outcomes for ICU survivors.
How similar studies have performed: While there is limited global evidence on this specific approach, the study addresses a critical gap in care for ICU survivors, suggesting potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult ≥ 18 years * ICU stay ≥ 7 days * Ward stay ≥ 3 days * Nutritional therapy not restricted * Heterogeneous diseases Exclusion Criteria: * Patients \< 18 years * ICU \< 7 days * Ward stay \< 3 days * Advanced Care Planning with impact on nutritional therapy * Patients with palliative care * Metabolic derangements such as metabolic diseases * Pregnancy
Where this trial is running
Brussels
- UZ Brussel — Brussels, Belgium (Recruiting)
Study contacts
- Principal investigator: Elisabeth De Waele, MD PhD — Universitair Ziekenhuis Brussel, Vrije universiteit Brussel
- Study coordinator: Zenzi Rosseel, PharmD
- Email: zenzi.rosseel@uzbrussel.be
- Phone: 003224763344
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.